ArticleJournal of the National Cancer Institute2008

Persistent LYN signaling in imatinib-resistant, BCR-ABL-independent chronic myelogenous leukemia.

Thomas O'Hare et al.PubMed ↗Publisher ↗

No numbers read from the abstract.